Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Gestational [pregnancy-induced] hypertension without significant proteinuria (O13)
Summary
Gestational hypertension without significant proteinuria is a pregnancy-related condition characterized by elevated blood pressure (≥140/90 mmHg) after 20 weeks of gestation in a previously normotensive individual, without substantial proteinuria (typically <300 mg/24 hours). It is distinct from chronic hypertension or preeclampsia and requires monitoring to rule out progression to more severe forms.
Causes
The exact cause is not fully understood, but it is thought to involve placental dysfunction, abnormal angiogenesis, or maternal vascular adaptation to pregnancy. Unlike preeclampsia, it lacks the widespread endothelial damage and proteinuria seen in that condition.
Risk Factors
- First pregnancy (primigravidity).
- Advanced maternal age (≥35 years).
- Preexisting conditions like chronic hypertension, diabetes, or renal disease.
- Multiple gestation (twins or higher-order pregnancies).
- Family history of gestational hypertension or preeclampsia.
- Obesity (BMI ≥30 kg/m²).
Symptoms
- Elevated blood pressure (≥140/90 mmHg) after 20 weeks of gestation.
- Absence of significant proteinuria (typically <300 mg/24 hours).
- May be asymptomatic or present with mild headaches, visual changes, or edema (though edema alone is not diagnostic).
Diagnosis
Diagnosis is confirmed by measuring blood pressure ≥140/90 mmHg on two separate occasions at least 4 hours apart after 20 weeks of gestation in a previously normotensive patient, with no significant proteinuria. Urine protein testing (e.g., dipstick or 24-hour collection) is performed to exclude preeclampsia. Other causes of hypertension (e.g., chronic hypertension) must be ruled out.
Treatment Options
- Monitoring: Regular blood pressure checks, fetal growth assessments, and urine protein testing.
- Lifestyle modifications: Rest, reduced sodium intake, and activity restrictions if needed.
- Medications: Antihypertensives (e.g., labetalol, methyldopa) may be used if blood pressure is severely elevated (≥160/110 mmHg) or symptoms develop.
- Delivery planning: Timing depends on gestational age, maternal/fetal status, and blood pressure control.
Prognosis and Follow-Up
Most cases resolve postpartum, but blood pressure should be monitored for 6–12 weeks to confirm normalization. Long-term follow-up may be needed if preexisting hypertension is suspected. Women with gestational hypertension have an increased risk of developing chronic hypertension later in life.
Complications
- Progression to preeclampsia or eclampsia (if proteinuria develops).
- Placental abruption.
- Intrauterine growth restriction (IUGR) or preterm birth.
- Maternal organ damage (rare, if untreated).
Lifestyle & Prevention
- Regular prenatal care to detect early signs.
- Balanced diet with adequate protein and reduced sodium.
- Avoid smoking and excessive alcohol.
- Manage preexisting conditions (e.g., diabetes, chronic hypertension) before pregnancy.
When to Seek Professional Help
Seek immediate care if experiencing severe headaches, visual disturbances, abdominal pain, or sudden swelling, as these may indicate progression to preeclampsia. Contact a healthcare provider for persistent elevated blood pressure or concerning symptoms.
Tips for Medical Coders
Code O13 is used for gestational hypertension without significant proteinuria. Documentation should confirm blood pressure measurements (≥140/90 mmHg after 20 weeks), absence of proteinuria, and no history of chronic hypertension. Ensure timing (post-20 weeks) and lack of other hypertensive disorders of pregnancy are clearly documented.
O13 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.